Carter’s (NYSE:CRI – Get Free Report) is projected to announce its earnings results before the market opens on Tuesday, ...

BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price target lifted by Citigroup from $45.00 to $49.00 in a research ...

Despite cost pressures, both Citi and Jefferies remain bullish on IndiGo, citing strong demand trends, dominant market share, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Shares of the private sector lender in Monday's trade were seen gaining some ground despite overall weak market mood. At ...

Citi has reiterated its 'Buy' rating on IndiGo, raising its target price to Rs 5,200, citing improved yields in Q4FY25 due to ...

Banks must strike a balance between profitability and financial intermediation’ Atif Bajwa’s distinguished career spans over ...

Citigroup recently became the latest company to walk back its diversity, equity and inclusion initiatives due to political ...

Sabbatical leave is a deeply misunderstood corporate benefit. Once largely confined to academia, it is still a luxury in many ...

ASX 200 futures are down 64pts (-0.78%) as of 8:30 am AEDT. In a nutshell: US stocks tumbled on weaker-than-expected flash ...

Warren Buffett’s Berkshire Hathaway on Saturday joined a growing list of American companies to publicly change their approach ...

Despite its former support from Republicans, Lee Zeldin’s EPA is dismantling the $20 billion clean energy loan program.